Akèy › Sakom Ewing › Kalifòni › Los Angeles

Etid klinik pou Sakom Ewing nan Los Angeles, CA

6 etid pou Sakom Ewing ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)

Ap rekriteFaz 1

Cedars Sinai Medical Center, Los Angeles
University of California Los Angeles, Los Angeles

Laj 2 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07297979

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Ap rekriteFaz 1/2

Children's Hospital Los Angeles ( Site 1006), Los Angeles

6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Ap rekriteFaz 1

Valkyrie Clinical Trials, Los Angeles

Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933

Lurbinectedin in FET-Fused Tumors

Ap rekriteFaz 1/2

Cedars-Sinai Medical Center, Los Angeles

Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ap rekriteFaz 1/2

Children's Hospital Los Angeles, Los Angeles

12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Ap rekriteFaz 1/2

Children's Hospital of Los Angeles, Los Angeles

Laj 2 a 30 · Tout sèks · Mizajou Feb 3, 2026 · NCT05734066

Etid Sakom Ewing nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.